Cyclacel Pharmaceuticals Inc CYCCP:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/24/22 EDT
7.10UNCH (UNCH)
Volume
1
52 week range
5.17 - 11.17
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.10
  • 52 Week High11.17
  • 52 Week High Date07/13/21
  • 52 Week Low5.17
  • 52 Week Low Date01/27/22

Key Stats

  • Market Cap13.79M
  • Shares Out9.99M
  • 10 Day Average Volume0.00M
  • Dividend0.60
  • Dividend Yield8.45%
  • Beta-
  • YTD % Change14.52

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.10
  • 52 Week High11.17
  • 52 Week High Date07/13/21
  • 52 Week Low5.17
  • 52 Week Low Date01/27/22
  • Market Cap13.79M
  • Shares Out9.99M
  • 10 Day Average Volume0.00M
  • Dividend0.60
  • Dividend Yield8.45%
  • Beta-
  • YTD % Change14.52

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date04/13/2022
  • Div Amount0.15
  • Split Date-
  • Split Factor-

Latest On Cyclacel Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The Company is focused on the field of cancer cell cycle biology with a vision to improve patient healthcare by translating insights in cancer biology into medicines that can overcome resistance and ultimately increase a patient’s overall survival. The Company's pipeline...
Christopher Henney Ph.D.
Independent Chairman of the Board
Spiro Rombotis
President, Chief Executive Officer, Director
Paul Mcbarron
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Secretary, Director
Address
200 Connell Dr Ste 1500
Berkeley Heights, NJ
07922-2811
United States